Fundraising Fox
/Companies
Sign in

RhoDx

4 employees on LinkedIn · 1 known investors

Find your way into RhoDx

Sign up to see every warm intro you have to RhoDx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the RhoDx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

RhoDx develops cell-free DNA and RNA enrichment technologies for liquid biopsy cancer diagnostics. The company provides ultra-sensitive mutation detection methods to improve the performance and accessibility of liquid biopsy testing.

BiotechDigital HealthMedical Devices

Founders & leadership

CRCharlie Rodi
Charlie RodiFounder and CSOCharlie Rodi held roles including Chief Technology Officer at Trovagene and EVP Genomics at Sequenom, where he worked on cancer detection technologies and circulating nucleic acid analysis. He is now Founder and Chief Scientific Officer of RhoDx, which develops cell-free DNA and RNA enrichment technologies for liquid biopsy cancer diagnostics.

Investors · 1

Related companies · 2

CareDxCareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.
MIRA DX, Inc.MiraDx develops genetic biomarker tests, such as PREVIOTOX and PROSTOX Ultra, that help physicians assess cancer patients' risk of treatment-related toxicity and response to therapies like immunotherapy and radiation. The company applies novel biomarkers, including the inherited KRAS-variant, to support more personalized cancer care decisions.

Companies working in the same space as RhoDx.

Frequently asked questions

What does RhoDx do?
RhoDx develops cell-free DNA and RNA enrichment technologies for liquid biopsy cancer diagnostics. The company provides ultra-sensitive mutation detection methods to improve the performance and accessibility of liquid biopsy testing.
Who founded RhoDx?
RhoDx was founded by Charlie Rodi.
Who are RhoDx's investors?
RhoDx's investors include BioGenerator Ventures.